Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.

Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y.

Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.

PMID:
18791928
2.

Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults.

Yin Z, Fujii H, Walshe T.

Hum Immunol. 2010 Dec;71(12):1187-90. doi: 10.1016/j.humimm.2010.08.006. Epub 2010 Aug 21.

PMID:
20732368
3.

Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.

Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M.

Oncol Rep. 2005 Jul;14(1):113-20.

PMID:
15944777
4.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
5.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
6.

Impaired function of circulating dendritic cells in patients with pancreatic cancer.

Yanagimoto H, Takai S, Satoi S, Toyokawa H, Takahashi K, Terakawa N, Kwon AH, Kamiyama Y.

Clin Immunol. 2005 Jan;114(1):52-60.

PMID:
15596409
7.

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M.

Anticancer Drugs. 1998 Apr;9(4):343-50.

PMID:
9635925
9.

GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.

Eksioglu EA, Mahmood SS, Chang M, Reddy V.

Exp Hematol. 2007 Aug;35(8):1163-71. Epub 2007 Jun 11.

PMID:
17562355
10.
11.

A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

Spierings EL, Fujii H, Sun B, Walshe T.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9.

12.

Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).

Reading C, Dowding C, Schramm B, Garsd A, Onizuka-Handa N, Stickney D, Frincke J.

Clin Microbiol Infect. 2006 Nov;12(11):1082-8.

13.

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB.

Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. Review.

PMID:
16197336
14.
15.

Regulation of alloimmune responses by dendritic cell subsets.

Lonial S, Torre C, David E, Harris W, Arellano M, Waller EK.

Exp Hematol. 2008 Oct;36(10):1309-17. doi: 10.1016/j.exphem.2008.04.021. Epub 2008 Jul 11.

PMID:
18620796
16.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
17.

Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.

Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, Vossenkaemper A, Rovedatti L, Leakey NA, Croft NM, Troncone R, Corazza GR, Stagg AJ, Monteleone G, MacDonald TT.

Gastroenterology. 2007 Oct;133(4):1175-87. Epub 2007 Aug 14.

PMID:
17919493
18.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
19.

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.

Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G.

Am J Surg. 2008 Apr;195(4):537-45. doi: 10.1016/j.amjsurg.2007.05.045.

PMID:
18304499
20.

Effects of monomethylfumarate on dendritic cell differentiation.

Litjens NH, Rademaker M, Ravensbergen B, Thio HB, van Dissel JT, Nibbering PH.

Br J Dermatol. 2006 Feb;154(2):211-7.

PMID:
16433787

Supplemental Content

Support Center